Sign In
Buy KPTI
Karyopharm Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 3.82. In total, the insiders bought 753.98K and sold 51.37K KPTI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
3.82 |
| ● Buy | 753.98K shares |
| ● Sell | 51.37K shares |
|
56% Buy Activity
Strong Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 21, 2026 Buy |
Greene Barry E Director |
15 508 Value: $125.0K |
||
|
May 21, 2026 Buy |
Bohlin Garen G Director |
15 508 Value: $125.0K |
||
|
May 21, 2026 Buy |
Su Zhen Director |
15 508 Value: $125.0K |
||
|
May 21, 2026 Buy |
Schor Chen Director |
15 508 Value: $125.0K |
||
|
May 21, 2026 Buy |
Pakianathan Deepika Director |
15 508 Value: $125.0K |
||
|
May 21, 2026 Buy |
Oliger Christy J. Director |
15 508 Value: $125.0K |
||
|
May 14, 2026 Sell |
Mano Michael EVP, Clo&secretary |
266 Value: $3K |
||
|
May 14, 2026 Sell |
Paulson Richard A. President And CEO |
2 203 Value: $20.9K |
||
|
May 14, 2026 Sell |
Abate Kristin Chief Accounting Officer |
53 Value: $504 |
||
|
May 14, 2026 Sell |
Cheng Sohanya Roshan EVP & Chief Commercial Officer |
324 Value: $3K |
||
|
May 14, 2026 Sell |
Poulton Stuart EVP, Chief Development Officer |
403 Value: $4K |
||
|
May 14, 2026 Sell |
Rangwala Reshma EVP & Chief Medical Officer |
408 Value: $4K |
||
|
May 13, 2026 Buy |
Mano Michael EVP, Clo&secretary |
700 Value: $6K |
||
|
May 13, 2026 Buy |
Paulson Richard A. President And CEO |
4 920 Value: $43.5K |
||
|
May 13, 2026 Buy |
Abate Kristin Chief Accounting Officer |
121 Value: $1K |
||
|
May 13, 2026 Buy |
Cheng Sohanya Roshan EVP & Chief Commercial Officer |
947 Value: $8K |
||
|
May 13, 2026 Buy |
Poulton Stuart EVP, Chief Development Officer |
896 Value: $8K |
||
|
May 13, 2026 Buy |
Rangwala Reshma EVP & Chief Medical Officer |
947 Value: $8K |
||
|
Apr 21, 2026 Sell |
Rangwala Reshma EVP & Chief Medical Officer |
449 Value: $4K |
||
|
Mar 02, 2026 Sell |
Mano Michael EVP, Clo&secretary |
3 526 Value: $33.2K |
||
|
Mar 02, 2026 Sell |
Cheng Sohanya Roshan EVP & Chief Commercial Officer |
4 604 Value: $43.3K |
||
|
Mar 02, 2026 Sell |
Rangwala Reshma EVP & Chief Medical Officer |
5 066 Value: $47.7K |
||
|
Mar 02, 2026 Sell |
Paulson Richard A. President And CEO |
12 361 Value: $116.3K |
||
|
Mar 02, 2026 Sell |
Poulton Stuart EVP, Chief Development Officer |
5 101 Value: $48.0K |
||
|
Feb 17, 2026 Sell |
Poulton Stuart EVP, Chief Development Officer |
378 Value: $3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
